Akorn Comments on Delaware Chancery Court Ruling

Go back to Akorn Comments on Delaware Chancery Court Ruling

Akorn (AKRX) PT Lowered to $10 at RBC Capital

October 2, 2018 7:17 AM EDT

RBC Capital analyst Randall Stanicky lowered the price target on Akorn (NASDAQ: AKRX) to $10.00 (from $27.00) while maintaining a Sector Perform rating after the negative case scenario was delivered to AKRX in a decision which means FRE will not be forced to close at $34 per... More

Akorn (AKRX) 'Worst-Case Scenario', Stock Could Settle ~$6-$8 Today - RBC

October 1, 2018 10:17 AM EDT

RBC Capital analyst Randall Stanicky weighed in on Akorn (NASDAQ: AKRX) following a negative decision in the Fresenius merger case. Stanicky called this a "worst-case scenario" for AKRX and thinks the stock could settle in the ~$6-8 range today.

"Our 2019E EBITDA is $130... More

Akorn (AKRX) Halted Now on LUDP

October 1, 2018 9:57 AM EDT

Akorn (NASDAQ: AKRX) Halted Now on LUDP

... More

Akorn (AKRX) to Resume Trading at 9:55 am ET

October 1, 2018 9:36 AM EDT

Akorn (NASDAQ: AKRX) to Resume Trading at 9:55 am ET

... More